Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO)

NCT ID: NCT06026384

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-27

Study Completion Date

2024-04-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this interventional pilot study is to test and evaluate different information materials created to heighten participants cancer literacy, cancer prevention beliefs, and subsequent intention for behavioral changes. Forty individuals, intended to cover a broad socioeconomic background, will participate in the pilot study. Based on the results of this pilot study, the information materials will be adapted for the following main study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CLARO aims to answer the question, how information materials should be designed to strengthen optimistic beliefs on cancer prevention and to indirectly facilitate the acquisition of cancer literacy.

Four different information materials were developed and will be tested in this pilot study (2x2-design: text or animation-based / narrative or non-narrative). Participants will take part in a 30- to 40-minute survey. As part of the study, they will be randomly assigned to one of the information materials, and asked to evaluate it in depth, both quantitatively and qualitatively. The interviews will be conducted individually and face to face.

Recruitment: Two research assistants will approach potential participants at a shopping center in Heidelberg, Germany, to invite them to participate in the study. Participants will receive a leaflet with further details and contact information. Those interested will be able to participate immediately at a designated room next to the center, provided by the National Cancer Prevention Center, where all interviews will take place, or schedule an appointment via email. As an incentive, participants will receive 30€ via bank transfer upon completing the interview.

Randomization Procedure: Simple randomization - a research assistant will use an Excel spreadsheet to generate random participant codes, which will then be integrated into LimeSurvey to ensure a closed survey environment. The list of codes will be password protected and not accessible to the two research assistants who will conduct the interviews. LimeSurvey will then assign individual codes to participants. Participant codes and allocation details will then be printed on paper and placed within sealed envelopes. Interviewers will then use these envelopes to select the corresponding intervention guide.

Semi-Structured Interview: Post-intervention, participants will take part in a semi-structured interview. With participant permission, all interviews will be audio-recorded on VLC media player. The interviews will be conducted by two research assistants with a background in psychology and previous training on the interview technique.

Transcription: The audio recordings will be transcribed verbatim by the two research assistants using the MAXQDA 2022 (VERBI Software, 2021) and will be reviewed by the principal investigators for accuracy. The interviews, original transcriptions, and data analysis will be in German. All quotes will be translated into English and back-translated by two independent members of the research team to ensure that the meaning will be preserved.

By using a mixed method approach the study will combine quantitative and qualitative methods addressing the following research questions:

Quantitative:

* What is the sample's socio-demographics? (e.g. age, gender, highest educational degree, current occupational status, and income)
* Has there already been personal contact with people with cancer (e.g. through own cancer or cancer in the family)?
* What is the level of engagement in health behaviours (smoking, healthy eating, exercise, BMI)?
* How strongly are Cancer Prevention Beliefs and Cancer Information Overload represented?
* How much do the participants like the material shown? (three questions on satisfaction with the material as well as possible counter-argumentation in order to exclude distortions due to social desirability)
* Can the people in the narrative conditions identify with the characters shown?

Qualitative:

* Do the participants like the materials?
* Is there something wrong with the quality of the materials? (e.g., quality of sound \& images, presentation of animated figures, font size, readability...)
* Are the materials comprehensible?
* Is the amount of information appropriate? If not, is it too less or too much?
* Is the information given convincing?
* What are the most important insights gained from the materials? Do any of the information have novelty value?
* Are the given recommendations perceived as helpful?
* Are there ways to improve the materials?
* Might anyone feel excluded or offended by the information?

An inductive content analysis will be carried out to analyse the qualitative data obtained.

The results of the CLARO pilot study will help to improve the intervention materials that will be used for the subsequent main study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-Narrative Text

A short text (480 words) that deals with the preventability of cancer cases. It shows that lifestyle factors such as smoking, unhealthy diet, obesity and physical inactivity are responsible for about 40% of cancer cases. It also suggests ways to reduce the risk of cancer through behavioural changes in these areas. A special focus is on nutrition and physical activity. The text was developed on the basis of the Protection Motivation Theory.

Group Type EXPERIMENTAL

text in non-narrative form

Intervention Type OTHER

Participants will be asked to read a text and give feedback afterwards

Narrative Text

The narrative text contains the same information as the non-narrative text, except that it is built into a story. This makes the text slightly longer at 725 words. The text is about a main character and two work colleagues who share their personal experiences about nutrition and exercise.

Group Type EXPERIMENTAL

text in narrative form

Intervention Type OTHER

Participants will be asked to read a text and give feedback afterwards

Non-Narrative Animation

The animation with a total duration of 3:12 min is based on the text in non-narrative form and aims to be as fully comparable as possible.

Group Type EXPERIMENTAL

animated video in non-narrative form

Intervention Type OTHER

Participants will be asked to watch a video and give feedback afterwards

Narrative Animation

The animaion (3:45 min) is based on the text in narrative form and aims to be as fully comparable as possible.

Group Type EXPERIMENTAL

animated video in narrative form

Intervention Type OTHER

Participants will be asked to watch a video and give feedback afterwards

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

text in non-narrative form

Participants will be asked to read a text and give feedback afterwards

Intervention Type OTHER

text in narrative form

Participants will be asked to read a text and give feedback afterwards

Intervention Type OTHER

animated video in non-narrative form

Participants will be asked to watch a video and give feedback afterwards

Intervention Type OTHER

animated video in narrative form

Participants will be asked to watch a video and give feedback afterwards

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18 and 70 years old
* Being able to speak and understand german

Exclusion Criteria

\- Not being able and willing to provide informed consent and complete questionnaires
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Music, Drama, and Media Hannover

UNKNOWN

Sponsor Role collaborator

German Cancer Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen Steindorf, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

German Cancer Research Center

Alexander Haussmann, Dr.

Role: PRINCIPAL_INVESTIGATOR

German Cancer Research Center

Florian Herbolsheimer, Dr.

Role: PRINCIPAL_INVESTIGATOR

German Cancer Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

German Cancer Research Center

Heidelberg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

70114759

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CLARO Pilot

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Cancer Nurse Navigators on Patient Outcomes
NCT01902823 TERMINATED PHASE2/PHASE3